A host-protein based assay to differentiate between bacterial and viral infections in preschool children (OPPORTUNITY): a double-blind, multicentre, validation study

The Lancet Infectious Diseases

Volumn 17, Issue 4, 2017, Pages 431-440

  van Houten, Chantal B ^a   de Groot, Joris A H ^a   Klein, Adi ^b   Srugo, Isaac ^c   Chistyakov, Irena ^c   de Waal, Wouter ^d   Meijssen, Clemens B ^e   Avis, Wim ^f   Wolfs, Tom F W ^a   Shachor Meyouhas, Yael ^g   Stein, Michal ^h   Sanders, Elisabeth A M ^a   Bont, Louis J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b HILLEL YAFFE MEDICAL CENTER   (Israel)

^c BNAI ZION MEDICAL CENTER   (Israel)

^d DEPARTMENT OF SURGERY   (Netherlands)

^e MEANDER MEDICAL CENTER   (Netherlands)

^f GELDERSE VALLEI HOSPITAL   (Netherlands)

^g Ruth Rappaport Children's Hospital   (Israel)

^h WOLFSON MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; PROCALCITONIN; BIOLOGICAL MARKER;

ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BLOOD CULTURE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; FEVER; FOLLOW UP; HUMAN; INFANT; LENGTH OF STAY; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NOSE SMEAR; OUTCOME ASSESSMENT; PERTUSSIS; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DETERMINATION; SECONDARY ANALYSIS; SENSITIVITY AND SPECIFICITY; URINE CULTURE; VALIDATION STUDY; VIRUS INFECTION; BACTERIAL INFECTIONS; BLOOD; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; ISRAEL; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES;

BACTERIAL INFECTIONS; BIOMARKERS; C-REACTIVE PROTEIN; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DOUBLE-BLIND METHOD; FEMALE; FEVER; HUMANS; INFANT; ISRAEL; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS; SENSITIVITY AND SPECIFICITY; VIRUS DISEASES;

EID: 85010662182     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(16)30519-9     Document Type: Article

References (32)

1. 1 Kronman, MP, Zhou, C, Mangione-Smith, R, Bacterial prevalence and antimicrobial prescribing trends for acute respiratory tract infections. Pediatrics 134 (2014), e956–e965.
2. 2 Chancey, RJ, Jhaveri, R, Fever without localizing signs in children: a review in the post-Hib and postpneumococcal era. Minerva Pediatr 61 (2009), 489–501.
3. 3 Laxminarayan, R, Duse, A, Wattal, C, et al. Antibiotic resistance—the need for global solutions. Lancet Infect Dis 13 (2013), 1057–1098.
4. 4 ECDC/EMEA. Technical Report. The bacterial challenge: time to react. http://ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf, 2009 (accessed Aug 11, 2016).
5. 5 Craig, JC, Williams, GJ, Jones, M, et al. The accuracy of clinical symptoms and signs for the diagnosis of serious bacterial infection in young febrile children: prospective cohort study of 15 781 febrile illnesses. BMJ, 340, 2010, c1594.
6. 6 Metersky, ML, Sweeney, TA, Getzow, MB, Siddiqui, F, Nsa, W, Bratzler, DW, Antibiotic timing and diagnostic uncertainty in Medicare patients with pneumonia: is it reasonable to expect all patients to receive antibiotics within 4 hours?. Chest 130 (2006), 16–21.
7. 7 Van Zuijlen, DA, Schilder, AG, Van Balen, FA, Hoes, AW, National differences in incidence of acute mastoiditis: relationship to prescribing patterns of antibiotics for acute otitis media?. Pediatr Infect Dis J 20 (2001), 140–144.
8. 8 Oved, K, Cohen, A, Boico, O, et al. A novel host-proteome signature for distinguishing between acute bacterial and viral infections. PLoS One, 10, 2015, e0120012.
9. 9 Kapasi, AJ, Dittrich, S, González, IJ, Rodwell, TC, Host biomarkers for distinguishing bacterial from non-bacterial causes of acute febrile illness: a comprehensive review. PLoS One, 11, 2016, e0160278.
10. 10 Sparano, JA, Gray, RJ, Makower, DF, et al. Prospective validation of a 21-gene expression assay in breast cancer. N Engl J Med 373 (2015), 2005–2014.
11. 11 Bertens, LC, Broekhuizen, BD, Naaktgeboren, CA, et al. Use of expert panels to define the reference standard in diagnostic research: a systematic review of published methods and reporting. PLoS Med, 10, 2013, e1001531.
12. 12 Rutjes, AW, Reitsma, JB, Coomarasamy, A, Khan, KS, Bossuyt, PM, Evaluation of diagnostic tests when there is no gold standard. A review of methods. Health Technol Assess, 11, 2007, iii ix–51.
13. 13 Pencina, MJ, D'Agostino, RB Sr, Steyerberg, EW, Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30 (2011), 11–21.
14. 14 Lacour, AG, Zamora, SA, Gervaix, A, A score identifying serious bacterial infections in children with fever without source. Pediatr Infect Dis J 27 (2008), 654–656.
15. 15 Galetto-Lacour, A, Zamora, SA, Gervaix, A, Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics 112 (2003), 1054–1060.
16. 16 Korppi, M, Remes, S, Serum procalcitonin in pneumococcal pneumonia in children. Eur Respir J 17 (2001), 623–627.
17. 17 Gervaix, A, Galetto-Lacour, A, Gueron, T, et al. Usefulness of procalcitonin and C-reactive protein rapid tests for the management of children with urinary tract infection. Pediatr Infect Dis J 20 (2001), 507–511.
18. 18 Nijman, RG, Moll, HA, Smit, FJ, et al. C-reactive protein, procalcitonin and the lab-score for detecting serious bacterial infections in febrile children at the emergency department: a prospective observational study. Pediatr Infect Dis J 33 (2014), e273–e279.
19. 19 Nijman, RG, Vergouwe, Y, Thompson, M, et al. Clinical prediction model to aid emergency doctors managing febrile children at risk of serious bacterial infections: diagnostic study. BMJ, 346, 2013, f1706.
20. 20 Engelmann, I, Dubos, F, Lobert, PE, et al. Diagnosis of viral infections using myxovirus resistance protein A (MxA). Pediatrics 135 (2015), e985–e993.
21. 21 Falschlehner, C, Schaefer, U, Walczak, H, Following TRAIL's path in the immune system. Immunology 127 (2009), 145–154.
22. 22 Gyurkovska, V, Ivanovska, N, Distinct roles of TNF-related apoptosis-inducing ligand (TRAIL) in viral and bacterial infections: from pathogenesis to pathogen clearance. Inflamm Res 65 (2016), 427–437.
23. 23 Luster, AD, Unkeless, JC, Ravetch, JV, Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315 (1985), 672–676.
24. 24 Dufour, JH, Dziejman, M, Liu, MT, Leung, JH, Lane, TE, Luster, AD, IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 168 (2002), 3195–3204.
25. 25 Romero, AI, Lagging, M, Westin, J, et al. Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection. J Infect Dis 194 (2006), 895–903.
26. 26 Falconer, K, Askarieh, G, Weis, N, Hellstrand, K, Alaeus, A, Lagging, M, IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV. Scand J Infect Dis 42 (2010), 896–901.
27. 27 van der Does, Y, Tjikhoeri, A, Ramakers, C, Rood, PP, van Gorp, EC, Limper, M, TRAIL and IP-10 as biomarkers of viral infections in the emergency department. J Infect 72 (2016), 761–763.
28. 28 Chen, HL, Hung, CH, Tseng, HI, Yang, RC, Plasma IP-10 as a predictor of serious bacterial infection in infants less than 4 months of age. J Trop Pediatr 55 (2009), 103–108.
29. 29 Tsalik, EL, Henao, R, Nichols, M, et al. Host gene expression classifiers diagnose acute respiratory illness etiology. Sci Transl Med, 8, 2016, 322ra11.
30. 30 Reitsma, JB, Rutjes, AW, Khan, KS, Coomarasamy, A, Bossuyt, PM, A review of solutions for diagnostic accuracy studies with an imperfect or missing reference standard. J Clin Epidemiol 62 (2009), 797–806.
31. 31 Diez-Padrisa, N, Bassat, Q, Machevo, S, et al. Procalcitonin and C-reactive protein for invasive bacterial pneumonia diagnosis among children in Mozambique, a malaria-endemic area. PLoS One, 5, 2010, e13226.
32. 32 NICE. Fever in under 5s: assessment and initial management. https://www.nice.org.uk/guidance/cg160/resources/fever-in-under-5s-assessment-and-initial-management-35109685049029 (accessed July 19, 2016).